Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human C1-inhibitor

EU orphan designation number: EU/3/07/435   
Active ingredient: Recombinant human C1-inhibitor
Indication: Prevention of delayed graft function after solid organ transplantation
Sponsor: Pharming Group N.V.
Darwinweg 24, 2333 CR Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/02/2007 Orphan designation EMEA/OD/086/06 (2007)600 of 20/02/2007
22/06/2009 Change of name and/or address of sponsor